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Introduction
The cytokine TNF is of great interest in biomedical research. Low 
but chronic expression levels of TNF have been shown to be suffi-
cient for the development of diseases that have a large economic 
and social impact, e.g., rheumatoid arthritis and inflammatory 
bowel diseases (IBDs), such as Crohn disease. For the treatment 
of these and other diseases, TNF-inhibiting biological drugs 
have been shown to be a good option for patients not respond-
ing to first-line treatments, for example, with methotrexate (1). 
Although anti-TNF treatment is often successful, there are a 
number of problems associated with anti-TNF therapy, such as 
side effects, nonresponsiveness, and high cost (1). Interestingly, 
in such chronic diseases, acute exacerbations leading to inflam-
mation flares are observed that may be caused by several mole-
cules, including damage-associated molecular patterns (DAMPS) 
and cytokines and even an acute increase in TNF production (2). 
Therefore, understanding the impact, mechanism, and therapeu-
tic inhibition of acute TNF-induced toxicity is essential.
Although there is debate about their underlying mechanism 
of action, glucocorticoids (GCs) are used in the management of 
several acute inflammatory conditions. TNF-induced acute lethal 
inflammation represents an interesting mouse model, in which 
intestinal epithelial cells (IECs) have been described as the main 
target cells of TNF (3–5). In mice, at least 2 gut-associated mecha-
nisms contribute to loss of IEC barrier function, which is a crucial 
step in TNF-induced lethality: (a) loss of mucus in goblet cells and 
loss of antibacterial granules in Paneth cells and (b) damage and 
cell death in the IEC layer (5, 6).
GCs protect against TNF-induced lethal shock and TNF- 
induced intestinal permeability (5). GCs, such as dexamethasone 
(DEX), bind and activate the glucocorticoid receptor (GR) (7). 
They are used to treat a variety of inflammatory disorders, such 
as rheumatoid arthritis and IBDs (8). After binding, GR moves to 
the nucleus and regulates gene transcription as a monomer or as a 
homodimer. For a long time, the antiinflammatory effects of GCs 
were believed to result mainly from tethering (i.e., protein-pro-
tein interactions) of monomeric GR to inflammatory transcrip-
tion factors, such as NF-κB and AP-1. However, more recent 
research indicates that GR homodimers, which form a DNA-bind-
ing transcription factor, are essential for mediating the antiin-
flammatory properties of GCs in acute inflammatory settings, 
such as systemic inflammatory response syndrome (SIRS) (9, 10). 
Most of these data are based on findings in GRdim/dim mice. These 
mice express a mutant version of GR, carrying a missense point 
mutation (A458T) that leads to reduced GR dimerization and 
DNA binding, yet maintains an intact monomer profile (11, 12). 
Upon injection of synthetic GCs, GRdim/dim mice show significantly 
reduced expression of GC response element (GRE) responsive 
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Results
Intestinal epithelial GR and GR dimers play an essential role in protec-
tion against TNF-induced lethality, gut permeability, and cell death. 
We previously showed that GRdim/dim mice display a significant 
increase in sensitivity toward TNF-induced lethality and that TNF 
lethality is linked with apparent loss of goblet cells and Paneth 
cells and permeability of the IECs (5, 9). Hence, we decided to 
study the role of GR dimers in the intestinal epithelium during 
TNF-induced SIRS. GRVillinKO mice, which selectively lack a func-
tional GR-coding gene (Nr3c1) in IECs, were used (16). GRVillinKO 
and control GRfl/fl mice were injected with a single dose of 35 μg 
TNF, and survival was monitored. GRVillinKO mice were significantly 
more sensitive compared with the control GRfl/fl mice (Figure 1A). 
It has been known for a long time that injection of GCs protects 
against TNF-induced lethal shock (7). Interestingly, DEX could 
not protect GRVillinKO mice (Figure 1A), strongly indicating that pro-
tection by DEX requires GR expression in IECs.
To investigate the importance of GR dimers in protection 
against TNF lethality by exogenous GCs, we pretreated GRWT/WT 
and GRdim/dim mice with 10 mg/kg DEX or PBS, followed by increas-
ing doses of TNF. Survival was monitored (Figure 1B), and an LD50 
was defined for all mouse groups (Figure 1C). GRdim/dim mice dis-
played a higher sensitivity to TNF compared with GRWT/WT mice, 
with LD50 values of, respectively, 10 μg and 30.5 μg per mouse. In 
GRWT/WT mice, a single injection of DEX increased the LD50 of TNF 
over 3 times (from 30.5 μg to 96.8 μg per mouse), but in GRdim/dim 
mice, DEX had no significant protective effect and increased the 
LD50 from 10 μg to 11.9 μg per mouse. Our data suggest an essential 
role for IEC GR and, in particular, an optimal dimerization func-
tion in resistance against TNF-induced lethal shock, in both the 
absence and presence of exogenous GCs.
Next, we investigated whether GR dimers in IECs protect 
against TNF by reducing intestinal permeability previously shown 
to be strongly linked with TNF lethality (5). We studied the intes-
tinal permeability and cell death of IECs in the ileum of GRWT/WT 
and GRdim/dim mice after TNF challenge. In both groups of mice, we 
used 12.5 μg TNF, which is a lethal dose in GRdim/dim mice, but is not 
lethal in GRWT/WT mice. In contrast to GRWT/WT mice, GRdim/dim mice 
displayed significant increased intestinal permeability determined 
via FITC-dextran leakage into the blood upon oral gavage (Figure 
1D) and bowel damage as judged by H&E staining after TNF chal-
lenge (Figure 1E). GRdim/dim mice also displayed TNF-induced cell 
death of IECs, while this was virtually absent in GRWT/WT mice, as 
quantified by TUNEL stainings. Positive red signals were particu-
larly prominent at the villi tops and less so in the crypts (Figure 1F).
GR dimers are essential for suppressing STAT1 expression and 
activity specifically in the gut. In order to investigate why GRdim/dim 
mice are sensitive to these TNF-induced effects on IECs, we 
performed an RNA-sequencing (RNA-seq) analysis of IECs of 
GRWT/WT and GRdim/dim mice 8 hours after injection with PBS or 
with TNF. In control PBS-injected mice, 460 and 240 genes 
showed significant up- and downregulation, respectively, in 
GRdim/dim compared with GRWT/WT IECs (Supplemental Table 1; 
supplemental material available online with this article; https://
doi.org/10.1172/JCI96636DS1). Known motif analysis of the 
differentially expressed (DE) genes by HOMER (http://homer.
ucsd.edu/homer/ngs/analyzeRNA.html) revealed a significant 
target genes (9, 13, 14). The GRdim/dim mutant protein binds much 
less strongly to the classical type imperfect palindrome GRE 
(AGAACA(N)3TGTTCT) (12). As described by Surjit et al., GR 
dimers additionally downregulate several hundreds of genes by 
interaction with a short inverted repeat negative GRE (IR-nGRE), 
defined as (CTCC(N)0-2GGAGA) (15). GR
dim/dim mice are extreme-
ly sensitive to contact hypersensitivity, endotoxemia, sepsis, and 
TNF-induced SIRS (9, 10). Antiinflammatory pathways induced 
by GR dimers are hampered in GRdim/dim mice. For example, a 
crucial role for the GC-inducible and GR dimer–dependent gene 
Dusp1, encoding MKP1, was described in the TNF model and for 
the Il1ra gene encoding the IL1 receptor antagonist in the endo-
toxemia model (9, 10).
Here, we studied the mechanism by which GR dimers control 
TNF-mediated pathological changes at the level of the IECs. We 
measured genome-wide mRNA expression profiles of PBS-, TNF-, 
and DEX-stimulated IECs of GRWT/WT and GRdim/dim mice. In non-
stimulated conditions, we found an IEC-specific IFN-stimulated 
gene (ISG) signature in GRdim/dim mice, likely driven by STAT1 and 
strongly reduced by antibiotics treatment. Our data suggest a tight 
interplay among gut microbiota, induction of ISGs, and repression 
by locally produced GCs and GR dimers. They also explain why 
GRdim/dim mice are extremely sensitive to SIRS and why exogenous 
GCs, such as DEX, fail to protect GRdim/dim mice against TNF- 
induced intestinal permeability and lethality. Among the ISGs 
induced by TNF, but poorly controlled in GRdim/dim mice, are genes 
essential in necroptosis. Ripk3, Zbp1, and Mlkl were identified, sug-
gesting that necroptosis is a process promoted by the microbiome 
and IFNs and controlled by dimeric GR. Therefore, we conclude 
that under physiological conditions, the microbiota sustain a local 
GC production in order to prevent a detrimental ISG expression 
signature induced by the very same microbiota in a GR dimer–
dependent way. Failure of this protective loop leads to extreme 
sensitization for cell death in IECs and TNF-induced gut perme-
ability and subsequent lethality.
Figure 1. IEC GR and GR dimers play an essential role in protection 
against TNF-induced lethality, gut permeability, damage, and cell 
death. (A) GRfl/fl (n = 14 per group, black) and GRVillinKO mice (n = 7 per 
group, white) were pretreated with PBS (squares) or with 10 mg/kg DEX 
(triangles). Thirty minutes later, mice were injected with 35 μg TNF, 
and lethality was monitored. P values for survival curves were analyzed 
with a log-rank test (combined data of 2 independent experiments). (B) 
TNF dose-response curves of GRWT/WT (black) and GRdim/dim (white) mice 
pretreated with PBS (squares) or with 10 mg/kg DEX (triangles) for 30 
minutes (n = 8–10 per group; combined data of 2 independent experi-
ments). (C) LD50 values of TNF are depicted on top of each bar for each 
group. 95% confidence intervals were calculated for the LD50 of each 
group. (D–F) GRWT/WT and GRdim/dim mice were injected with PBS or 12.5 μg 
TNF (n = 10 per group; combined data of 2 independent experiments). 
Asterisks refer to significant differences compared with PBS control, 
unless indicated otherwise. (D) Relative permeability, 8 hours after 
TNF challenge, is based upon systemic appearance of orally gavaged 
FITC-dextran in plasma samples. Standard H&E (E) and TUNEL staining 
(F) on ileum samples 8 hours after TNF were scored in order to calculate 
bowel damage and TUNEL scores, respectively. Notice a perfect appear-
ance of GRWT/WT villi, but villi damage, shortening, cell death, and loss of 
goblet cells in GRdim/dim as well as TUNEL signals at villi tops and crypts. 
Scale bars: 50 μm. Bars represent mean ± SEM. P values were calculated 
using 2-way ANOVA. ****P < 0.0001 ***P ≤ 0.001; **P ≤ 0.01; *P ≤ 0.05.
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dependent way, the gene should contain one or more negative or 
inhibitory GREs in its promoter. By motif analysis, we identified 
2 so-called IR-nGRE elements, as previously defined (15), in the 
promoter of STAT1: IR-nGRE1 with sequence CACCTGGAGA 
and IR-nGRE2 with sequence CTCCAGGACA at positions –2841 
and –757 relative to the transcription start site, respectively. We 
studied GR binding to these elements via ChIP on ileum tissue 
extracts (Figure 2G). In the graph, data are represented as the fold 
change of the GR-specific H300 antibody to the IgG control, thus 
showing specific recruitment of GR to both IR-nGRE elements in 
the STAT1 promoter (ratio GR to IgG control). In basal conditions, 
GR was recruited to the IR-nGRE elements in the STAT1 promot-
er in both GRWT/WT mice and GRdim/dim mice, as shown by a 2-fold 
change. Interestingly, GR was substantial more recruited to these 
elements upon DEX treatment in GRWT/WT mice compared with 
DEX-treated GRdim/dim mice. These data potentially validate the 
IR-nGRE elements in the STAT1 promoter as GR dimer–bound 
elements that might be involved in the GR dimer–dependent 
repression of Stat1 gene expression.
The IEC-specific ISG signature and corticosterone production 
in GRdim/dim mice are modulated by the gut microbiome. Interest-
ingly, the increased expression of Stat1 mRNA observed in 
GRdim/dim mice was only observed in the intestinal epithelium 
and not in other organs, such as liver, macrophages, spleen, and 
adrenal glands (Figure 3A). The gut is a unique organ in which 
local GCs are produced and the gut microbiota are present (19). 
Microbiota are known to trigger signaling pathways, leading 
to the production of IFNs and activation of their signaling cas-
cades (20–22). We hypothesize that, under basal GR WT condi-
tions, IFN signaling in IECs is stimulated by the microbiota, but 
that this IFN response is controlled by local GC production that 
leads to low but important GR dimer–repressor activity.
To investigate this hypothesis, we studied the effect of the 
microbiome on basal gene expression in the IECs of GRWT/WT and 
GRdim/dim mice. Both groups of mice were treated with an antibiotic 
cocktail (+AB) for 3 weeks to deplete the bacteria, which was con-
firmed by plating out stool samples. In both groups of mice, antibi-
otic treatment reduced Stat1 and Ifit1 expression in IECs (Figure 3, 
B and C). Following mRNA expression, total STAT1 protein levels 
were reduced in both groups of mice after antibiotic treatment. In 
addition, a downward trend in the levels of phosphorylated STAT1 
(p-STAT1) was observed in GRdim/dim mice only (P = 0.07), as there 
are no p-STAT1 levels measurable in GRWT/WT mice (Figure 2, D 
and E). Interestingly, in GRdim/dim mice, the levels of Stat1 and Ifit1 
mRNA after antibiotic treatment remained higher than in untreat-
ed GRWT/WT mice, suggesting not only that the triggering of TLRs 
or IFN-β production by the antibiotic-sensitive microbiota induces 
the ISG signature in GRdim/dim mice, but also that additional factors, 
e.g., antibiotic-resistant bacteria, viruses, and fungi, are involved. 
The reduction in the ISG signature by antibiotics was somewhat 
reflected in the sensitivity to TNF-induced lethality because anti-
biotic-treated GRWT/WT and GRdim/dim mice were found to be partly 
protected (Figure 3D).
Next to adrenal cortical cells, IECs are known to produce 
GCs (19). Therefore, local stimulation of corticosterone (CS) pro-
duction by microbiota components could be an additional factor 
needed to control the ISG signature in the IECs. To address this, 
enrichment of ISRE, IRF1, and IRF2 motif–containing genes 
in IECs of GRdim/dim compared with GRWT/WT mice (Figure 2A). 
For example, upregulation of Ifit1, Stat1, Irf8, and Irf1 in IECs 
of GRdim/dim mice was found (Figure 2B). Additionally, Supple-
mental Figure 1 displays a more extensive heat map of ISGs, and 
Supplemental Table 2 lists all ISGs that are expressed at higher 
and lower levels in GRdim/dim compared with GRWT/WT IECs. These 
data were confirmed via quantitative PCR (qPCR) (Figure 2C). 
Out of 460 genes expressed significantly higher in IECs of 
GRdim/dim mice, 228 were genes defined as belonging to the Inter-
ferome database (17), which is a much higher frequency than 
expected by chance (hypergeometric test P = 1.61 × 10–66).
The induction of ISGs, such as Ifit1, is under the control of 
the transcription factor complex IFN-stimulated gene factor 3 
(ISGF3), which consists of STAT1, STAT2, and IRF9 (18). In agree-
ment with the fact that many of the STAT1-responsive ISG genes 
are upregulated in GRdim/dim mice, suggesting an active ISGF3 
complex, we found that STAT1 protein levels were increased in 
GRdim/dim mice compared with GRWT/WT mice and that STAT1 was 
only phosphorylated in the IECs of GRdim/dim mice (Figure 2, D 
and E). Furthermore, an ISG signature was detected in the IECs 
of GRVillinKO mice (Figure 2F), suggesting that the ISG signature is 
mediated by a lack of local (dimeric) GR signaling.
To confirm that the ISG signature in IECs of GRdim/dim mice is 
also observed at the protein level, we performed a proteome-wide 
mass spectrometry (liquid chromatography–tandem mass spec-
trometry [LC-MS/MS]) experiment on ileum samples of GRWT/WT 
and GRdim/dim mice. Differential protein concentrations with a log-
fold change (LFC) of 1.0 and an adjusted P value of 0.05 are listed 
in Supplemental Figure 2. We found 32 proteins upregulated in 
GRdim/dim, including 17 known as IFN stimulated (18) (17/32 signifi-
cant enrichment of IFN proteins, P = 0.003), including STAT1.
A conceivable interpretation of our data is that GR mediates 
repression of ISGs via the control of STAT1 expression in a GR 
dimer–dependent way. To repress gene expression in a GR dimer–
Figure 2. ISGs are expressed in the IECs of naive GRdim/dim mice. (A–C) 
RNA-seq of IECs of GRWT/WT (black) and GRdim/dim (white) mice (n = 3 per 
group). (A) HOMER motif analysis of DE genes in GRdim/dim compared with 
GRWT/WT mice. Motifs with highest rank and their P values and q values 
are displayed. (B) Heat map of DE genes containing an ISRE and/or IRF-1 
element. (C) Confirmation of RNA-seq data with qPCR on independent 
new samples (n = 3 per group). Ifit1, Irf8, Irf1, and Stat1 mRNA expression 
are shown as mean ± SEM. P values were calculated using Student’s t test. 
(D–F) GRWT/WT and GRdim/dim mice received drinking water with or without 
antibiotics for 3 weeks, after which IEC samples were taken (n = 3 per 
group). (D) STAT1 and p-STAT1 protein levels were analyzed via Western 
blot using actin as a loading control. (E) Relative STAT1 and p-STAT1 signal 
intensities were quantified and normalized to ACTIN and STAT1 levels 
respectively. P values were calculated using 2-way ANOVA. (F) Stat1 and 
Ifit1 mRNA expression were determined in IECs of GRfl/fl (black) and GRVillinKO 
mice (white) via qPCR and are shown as mean ± SEM (n = 5 per group). 
P values were calculated using Student’s t test. (G) GR recruitment to 2 
IR-nGRE sites in the STAT1 promoter (IR-nGRE1 and IR-nGRE2). GRWT/WT 
(black) and GRdim/dim (white) mice were treated with PBS or 10 mg/kg DEX 
for 2 hours (n = 5 per group; combined data of 3 independent experiments). 
ChIP on IEC samples was performed against GR using an H300 antibody. 
Data were normalized to input for each sample and expressed as fold 
change of H300 to IgG control. P values were calculated using 2-way ANO-
VA. ****P < 0.0001;  ***P < 0.001; **P ≤ 0.01; *P ≤ 0.05.
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we first studied the impact of antibiotics on the expression of the 
Cyp11a1 and Cyp11b1 genes, which encode critical steroidogenic 
enzymes involved in CS synthesis, in IECs of GRWT/WT and GRdim/dim 
mice. In both mouse groups, the expression of these genes was 
reduced in IECs of mice subjected to antibiotics, supporting our 
hypothesis (Figure 3, E and F). Interestingly, the expression of 
Cyp11a1 and Cyp11b1 genes was higher in GRdim/dim mice compared 
with GRWT/WT mice. This correlates with the fact that both genes 
are known ISG genes and are found in the Interferome database 
(17). Next, the local production of CS in IECs in the absence of 
microbiota was determined. Interestingly, ex vivo CS production 
by ileum explants was significantly reduced by antibiotic treat-
ment in mice (Figure 3G). Serum CS levels, which are higher in 
GRdim/dim than GRWT/WT mice (23), were also reduced by about half 
by antibiotics (data not shown). Together, these data support our 
hypothesis that microbiota stimulate local CS production and 
activate GR dimers, which are essential in controlling the micro-
biota-stimulated ISG signature in the gut.
STAT1 and its responsive genes are master regulators of sensitivity to 
TNF. STAT1-deficient (STAT1–/–) mice exhibit strong IFN-signaling 
defects and do not display any of the physiological responses asso-
ciated with IFNs (24–26). In contrast to STAT1+/+ mice, full STAT1–/– 
Figure 3. The gut microbiota determine the gut-specific ISG signature in GRdim/dim mice and local GC production. (A) RNA was isolated from ileum, 
liver, bone marrow–derived macrophages (BMDM), spleen, and adrenal glands dissected from GRWT/WT (black) and GRdim/dim (white) mice. Stat1 mRNA 
expression was analyzed via qPCR (n = 4 per group). For each organ, different housekeeping genes were used for normalization. Expression in GRWT/WT  
mice was set as 1. P values were calculated using Student’s t test. (B–E) Effects of commensal bacteria depletion on ISG expression, p-STAT1 levels, 
TNF-induced lethality, and GC production. GRWT/WT and GRdim/dim mice were treated with antibiotics (+AB) for 3 weeks. IECs were isolated, and Stat1 (B) 
and Ifit1 (C) mRNA expression were determined via qPCR (n = 8 per group, combined data of 2 independent experiments). P values were calculated 
using 2-way ANOVA. (D) TNF dose-response curves of GRWT/WT and GRdim/dim mice treated with (triangles) or without (squares) antibiotics (n = 4–6 per 
dose). (E–G) Effects of antibiotics on GC production. GRWT/WT and GRdim/dim mice were treated with antibiotics for 3 weeks. Cyp11a1 (E) and Cyp11b1 (F) 
mRNA expression in IECs were determined via qPCR (n = 4 per group). P values were calculated using 2-way ANOVA. (G) GC production in supernatant 
of ileum explants of GRWT/WT mice treated without (–AB) or with antibiotics (+AB) (n = 5 per group). P values were calculated by Student’s t test. All bars 
represent mean ± SEM. ****P < 0.0001; ***P < 0.001; **P ≤ 0.01; *P ≤ 0.05.
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mice fail to express Ifit1, Ifit2, or other ISGs (including Cyp11a1 and 
Cyp11b1) in IECs in unstimulated conditions (Figure 4A). STAT1–/– 
mice were found to resist a lethal dose of TNF (Figure 4B) as well 
as TNF-induced intestinal permeability or cell death (Figure 4, C 
and D). These data support the idea that STAT1 is a crucial regu-
lator of TNF-induced intestinal permeability, IEC cell death, and 
subsequent lethality. Unfortunately, homozygous STAT1–/– GRdim/dim 
double-mutant mice were not viable. To investigate whether the 
upregulated and phosphorylated intestinal STAT1 is a master regu-
lator of GRdim/dim hypersensitivity to TNF, we administered the JAK/
STAT inhibitor tofacitinib (27). Tofacitinib (100 mg/kg) or vehicle 
was given orally to GRdim/dim mice. Mice received tofacitinib twice a 
day for 2 days before challenge with 20 μg TNF and 2 times (1 hour 
before and 8 hours after) on the day of the challenge. Compared 
with treatment with vehicle, tofacitinib treatment significantly pro-
tected GRdim/dim mice against TNF-induced lethality (Figure 4E).
To further explore how the gut ISG signature might be connect-
ed to the increased sensitivity of GRdim/dim mice to TNF, we studied 
Figure 4. STAT1 is a master regulator of TNF sensitivity. (A) RNA was isolated from IECs of STAT1+/+ (black bars) and STAT1–/– mice (white bars). Ifit1 and 
Ifit2 mRNA expression levels were determined via qPCR (n = 4 per group). P values were calculated by Student’s t test. (B–D) STAT1 mediates TNF-induced 
lethality, intestinal permeability, and cell death. (B) STAT1+/+ (black) and STAT1–/– (white) mice were injected with 35 μg TNF, and survival was monitored 
(n = 7 per group). Survival curves were analyzed with a log-rank test. (C) As a measure for intestinal permeability, systemic appearance of orally gavaged 
FITC-dextran in plasma samples was determined 8 hours after TNF injection in STAT1+/+ mice (PBS, n = 7; TNF, n = 14) and in STAT1–/– mice (PBS, n = 7; TNF, 
n = 15). (D) TUNEL staining was performed on ileum tissue sections and quantified (combined data of 2 independent experiments). P values were calculat-
ed using 2-way ANOVA. (E) STAT1 is an important regulator of GRdim/dim TNF sensitivity. Tofacitinib (100 mg/kg) or vehicle was given orally to GRdim/dim mice  
(n = 10 per group; combined data of 2 independent experiments). Mice received tofacitinib twice a day for 2 days before challenge (20 μg TNF) and 2 times 
(1 hour before and 8 hours after) on the day of challenge. Survival was monitored and analyzed with a log-rank test. (F) LFCs of TNF-induced ISGs, detect-
ed by RNA-seq, in IECs of GRWT/WT mice (black) or GRdim/dim mice (white) injected with 12.5 μg TNF (n = 4 per group). (G) Ifit1 and Ifit2 mRNA expression, 
measured by qPCR, in IECs of GRWT/WT and GRdim/dim, 8 hours after PBS or 12.5 μg TNF (n = 4 per group). P values were calculated using 2-way ANOVA. All 
bars represent mean ± SEM. ****P < 0.0001; ***P < 0.001; **P ≤ 0.01; *P ≤ 0.05.
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the Interferome database (17). In both GRWT/WT and GRdim/dim mice, 
a dose of 12.5 μg TNF induced an almost identical set of ISGs, but 
TNF induction of these genes was significantly higher in GRdim/dim 
than in GRWT/WT mice (Figure 4F, log y axis). This is also illustrated 
by the expression pattern of Ifit1 and Ifit2 (Figure 4G). Together, 
these results suggest a poorly controllable ISG induction in GRdim/dim 
mice upon TNF challenge. Based on the data with STAT1-deficient 
mice (Figure 4C) and our previous work using IFN- and IFN-recep-
tor-1–deficient mice (3), the insufficient control of ISG induction in 
GRdim/dim mice is likely to form the basis of their hypersensitivity to 
TNF-induced lethality.
gene-expression profiles in IECs of GRWT/WT and GRdim/dim mice 
challenged with different doses of TNF. Mice were injected with 
12.5 μg TNF, which is a sublethal dose in GRWT/WT mice (referred to 
as WT12.5), but is a lethal dose in GRdim/dim mice (DIM12.5). GRWT/WT 
mice were also challenged with a lethal dose (50 μg) of TNF (WT50). 
A comparison between the response to different doses of TNF is dis-
cussed in Supplemental Figure 3. Ingenuity Pathway Analysis (IPA) 
revealed that the major pathway activated by lethal doses of TNF 
in GRWT/WT and GRdim/dim mice is the IFN-signaling pathway. When 
focusing on all 2,029 genes that are significantly induced by TNF 
(across the 3 groups), 736 of these genes were identified as ISGs by 
Figure 5. Lack of protective effects of DEX against TNF-induced changes in the gut of GRdim/dim mice. (A–C) GRWT/WT (black) and GRdim/dim (white) mice were 
pretreated with vehicle or 10 mg/kg DEX for 30 minutes, followed by challenge with 50 μg or 12.5 μg TNF, respectively. (A) Eight hours after TNF challenge, 
systemic concentrations of FITC-dextran in plasma were determined after oral gavage and reflect relative intestinal permeability (n = 12–20 per group; 
combined data of 3 independent experiments). (B) Ileum was sampled 2 hours and 8 hours after TNF injection (n = 5 per group), then stained with H&E 
and bowel damage scores determined. (C) Sections were stained for TUNEL and quantified. All bars represent mean ± SEM. P values were calculated using 
2-way ANOVA. (D–F) RNA-seq results of IECs of GRWT/WT and GRdim/dim mice pretreated with 10 mg/kg DEX or PBS, followed 30 minutes later by a lethal 
dose of TNF (50 μg for GRWT/WT and 12.5 μg for GRdim/dim mice) or PBS. (D) Overview of the experimental protocol. For all groups, n = 3 per group. (E) Venn 
diagram of DE genes upon DEX treatment compared with PBS-stimulated conditions. (F) Overview of the most significant transcription factor–binding 
motifs found enriched in the DEX-induced (left panel) and DEX-reduced (right panel) genes in GRWT/WT mice, using HOMER. Motifs with the highest rank 
and their P values and q values. ****P < 0.0001; ***P < 0.001; **P ≤ 0.01; *P ≤ 0.05.
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The expression levels of these 3 genes, as determined by RNA-
seq, are depicted in Figure 6E (Ripk3) and Supplemental Table 3 
(Zbp1 and Mlkl). Based on the data in Figure 6E, it is clear that Ripk3 
is significantly more highly expressed in GRdim/dim mice compared 
with GRWT/WT mice in basal conditions and after stimulation with 
an equal dose of TNF (12.5 μg/mouse) in both groups. Moreover, 
expression of Ripk3 mRNA is less repressed by DEX pretreat-
ment in these mice. The function of these genes is strictly linked 
to necroptotic cell death (29). The induction of RIPK3 protein was 
measured by IHC on ileum sections (Figure 6F) and appeared more 
pronounced in the gut of GRdim/dim compared with GRWT/WT mice. 
The staining was particularly strong in crypts. Supporting a role for 
necroptosis, the extreme sensitivity for TNF-induced lethal SIRS of 
GRdim/dim mice was reverted by pretreatment with Nec1s (29), a spe-
cific necroptosis inhibitor (Figure 6G). These data combined sug-
gest that necroptosis is a contributing pathway that is more strongly 
induced by TNF in GRdim/dim mice, potentially because the Ripk3, 
Zbp1, and Mlkl genes are more strongly induced in these mice.
Discussion
GCs are powerful in protecting against the TNF-induced lethal 
shock model (7), but the mechanism of protection is not clear. Here, 
we show that DEX confers protection against TNF in GRWT/WT mice, 
yet fails to do so in GRdim/dim mice. Both GRdim/dim and GRVillinKO mice 
exhibit a stronger response to TNF with gut barrier leakiness. DEX 
failed to provide protection against TNF in both these mutant mice. 
GRdim/dim mice exhibited more structural damage and cell death of 
IECs in response to TNF.
RNA-seq analysis on IECs of GRWT/WT and GRdim/dim mice under 
basal conditions revealed an unexpected and strong IFN signature in 
GRdim/dim mice. The phosphorylation state of STAT1 in GRdim/dim mice 
implied that STAT1 is more transcriptionally active. The enhanced 
expression of Stat1 and ISGs depends on the GR, since the same ISG 
signature could be seen in IECs of GRVillinKO mice and, importantly, 
appeared to be IEC specific. Interestingly, the ISG signature in IECs 
of GRdim/dim mice was confirmed by a proteome-wide MS experiment: 
32 proteins were identified as substantially upregulated, including 17 
IFN-stimulated proteins, such as STAT1.
The RNA-seq analysis showed that, under basal conditions, 664 
genes were DE in GRdim/dim mice; of these, 460 were upregulated 
and 204 downregulated. This result is in contrast with the genome-
wide expression profiling by Frijters et al., in which no DE genes 
were found in liver samples of GRWT/WT and GRdim/dim mice. Based 
on their findings, the authors suggested that the GR dim mutation 
itself does not cause differential gene regulation (13). The discrep-
ancy between their liver and our IEC results might be explained by 
the fact that local GC production in the gut could lead to GR dimer 
formation even in the absence of exogenous ligand. It is important 
to note that recent studies in unchallenged mice suggest that, in the 
absence of synthetic ligand, the DNA-bound GR almost exclusively 
resides in its monomer form and that virtually the complete popu-
lation of GR forms GR dimers upon injection of pharmacological 
doses of ligand (14). Hence, it is plausible that, in organs where GCs 
are produced locally, CS levels rise to a level sufficient to support GR 
dimerization, leading to transactivation or repression of particular 
GR dimer–sensitive target genes. This mechanism may play a role 
in the IECs, as these are known to produce CS (19).
Lack of protective effects of exogenous GCs against TNF-induced 
changes in the gut of GRdim/dim mice. To study the effect of exogenous 
GCs on TNF-induced intestinal permeability, we pretreated mice 
with vehicle or DEX (minus 30 minutes) and challenged GRWT/WT and 
GRdim/dim mice with a lethal dose of TNF, 50 μg and 12.5 μg, respec-
tively. Eight hours after TNF challenge, the TNF-induced intestinal 
permeability was significantly decreased by DEX in GRWT/WT mice, 
but not in GRdim/dim mice (Figure 5A). To determine the damage of the 
intestine, ileum was sectioned 2 hours and 8 hours after TNF chal-
lenge and damage was quantified visually using the validated proto-
col (28), including scores for villus length, villus erosion, cell death, 
and loss of goblet cells (Figure 5B). TNF caused massive damage to 
the gut in all samples. DEX was able to protect partially against the 
TNF-induced damage to the villi in GRWT/WT mice, but not in GRdim/dim 
mice. TUNEL staining on ileum sections 8 hours after TNF chal-
lenge revealed more TUNEL activity induced by TNF in GRdim/dim 
compared with GRWT/WT mice. Moreover, DEX had a significant pro-
tective effect in GRWT/WT mice, but not in GRdim/dim mice (Figure 5C).
GR dimer–specific repression of ISGs, including necroptosis master 
switches Ripk3, Zbp1, and Mlkl. To identify the biological pathway 
behind the observed GR dimer–dependent protective effects in 
Figure 5, A–C, we studied the effects of DEX or PBS pretreatment 
(minus 30 minutes) on gene expression by RNA-seq of GRWT/WT 
and GRdim/dim IECs 8 hours after TNF or PBS. An overview of the 
numbers of DE genes (up and down) under DEX conditions, rel-
ative to noninduced (PBS injected) levels is provided in Figure 
5E. No specifically enriched motifs were found by HOMER in the 
GRdim/dim-specific regulated genes. As expected, one of the prom-
inent enriched motifs found in the family of GRWT/WT-specific 
DEX-induced genes is the classical GRE. Interestingly, the major 
motifs found in GRWT/WT-specific DEX downregulated genes are 
ISRE and IRF motifs (Figure 5F).
A dimer-specific repression of ISGs seems a plausible mech-
anism underlying the molecular basis of the GR dimer–specific 
protection of DEX against TNF-induced gut permeability and 
lethality. To investigate whether DEX represses TNF-induced 
ISRE genes more prominently in GRWT/WT compared with GRdim/dim 
mice, we studied Stat1 and Ifit1 gene-expression profiles in both 
mouse groups (Figure 6, A and B). Although DEX is able to repress 
TNF-induced expression of these genes, the process is less effi-
cient in GRdim/dim mice compared with GRWT/WT mice. As men-
tioned before, we found DEX-stimulated GR recruitment to both 
IR-nGRE elements in the STAT1 promoter upon DEX treatment, 
but only in GRWT/WT mice (Figure 2G). When evaluating the impact 
of DEX on transcriptional levels of TNF-induced ISGs specifically 
in GRWT/WT and GRdim/dim mice, we focused on 736 ISGs (induced by 
TNF and identified by the Interferome database; ref. 17) and stud-
ied the impact of DEX on the log-fold induction of these genes. As 
shown in Figure 6C, the reduced expression by DEX was found to 
be stronger in GRWT/WT mice compared with GRdim/dim mice (35% 
and 28%, respectively), suggesting poorer repression of ISGs by 
DEX in GRdim/dim mice. Next, we questioned whether DEX was able 
to significantly repress TNF-induced ISGs in GRWT/WT mice, but not 
in GRdim/dim mice, and found a list of 93 genes following this pattern 
(Figure 6D and Supplemental Table 3). Interestingly, this list con-
tains genes coding for proteins important in the induction of necro-
ptotic cell death, namely Ripk3, Zbp1, and Mlkl.
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elements with nGRE activity, leading to downregulation of gene 
expression. Several GRE elements have recently been described in 
the mouse Stat1 gene (36). Fifth, and of interest here, GR dimers 
inhibit STAT1 transcription via so-called IR-nGREs (consensus 
sequence: CTCC(N)0-2GGAGA), first described by Surjit et al., and 
present in the promoter of many genes, leading to transcriptional 
repression via binding of GR dimers (15). In silico analysis of the 
STAT1 promoter predicted 2 IR-nGRE elements (IR-nGRE1 and 
IR-nGRE2). Although we found no difference in GR occupancy 
on these elements between naive GRWT/WT and GRdim/dim mice, we 
clearly found GR recruitment after DEX injection in GRWT/WT mice, 
but not in GRdim/dim mice, suggesting a dimer-specific interaction. It 
is also important to note that, although Surjit et al. clearly showed 
that DEX-induced IR-nGRE–mediated repression was abolished 
in GRdim/dim mice, it is suggested that GR dimers are formed in a 
structurally alternative way on these elements (37). Sixth, since 
the genes that are downregulated by DEX in IECs in a GR dimer–
dependent way appear to be strongly enriched in IRF1 and ISRE 
sequences, GR dimers may bind to IRF1 on the one hand or STAT1, 
STAT2, or IRF9 on the other hand and form a transcriptionally 
inhibitory complex.
The genes coding for key enzymes of CS synthesis were 
found to be upregulated in naive GRdim/dim mice, which is com-
patible with the fact that they are known in the Interferome 
database as ISGs (17). Antibiotics downregulate expression of 
these genes and also downregulate IEC-specific production of 
CS. These data are in line with the hypothesis that IECs are stim-
ulated by gut flora to produce ISGs, including genes leading to 
local CS production, which triggers GR dimers to suppress this 
ISG signature at the level of STAT1. Larsson et al. showed dra-
matic transcriptional responses to microbiota in all segments of 
the gut by comparing the gene-expression profile of germ-free 
and conventionally raised WT mice (38). Similarly to what was 
shown in other studies (39), Larsson et al. observed a significant 
microbial induction of genes related to immunity. Moreover, 
sensing of microbial products by various receptors triggers ISG 
expression via IFN-β and IFN-α production (22).
IFNs are known to prime cells for subsequent inflammatory 
triggers (40). By RNA-seq in IECs of GRWT/WT and GRdim/dim mice, 
we found that TNF induces ISGs and that an equal dose in both 
groups of mice led to higher LFCs of ISG expression in GRdim/dim 
mice. IFN signaling and activation of IRF were the 2 most prom-
inent pathways predicted by IPA in GRdim/dim mice injected with a 
lethal dose of TNF compared with GRWT/WT mice injected with a 
lethal TNF dose. These data suggest that the increased sensitivity 
for TNF in GRdim/dim mice is based on an uncontrolled induction of 
ISGs, not on a priming sensu stricto.
Finally, to understand why GRdim/dim mice are not protected 
against TNF-induced permeability and lethality by exogenous 
GCs, we studied the impact of DEX on TNF-induced changes in 
IECs and performed genome-wide expression profiling via RNA-
seq in IECs of DEX- and DEX/TNF-treated GRWT/WT and GRdim/dim 
mice. DEX inhibits several TNF-induced physiological changes in 
a dimer-dependent way, namely gut permeability, gut damage, 
and cell death. The transcription factor–binding motifs found in 
the genes repressed by DEX in a dimer-specific way were ISRE 
and IRF elements only. This suggests a poor repression of ISGs in 
As an additional explanation for the gut specificity of this ISG 
signature, the role of the gut microbiota was investigated. Elim-
ination of this factor by antibiotics strongly (but not completely) 
reduced expression of Stat1 and other ISGs and led to some, albeit 
incomplete, protection against TNF-induced lethality in GRdim/dim 
mice. These results suggest a link between ISG signature and TNF 
sensitivity, which is in line with earlier data using IFN receptor–
KO mice (3). The fact that antibiotics only partly protect against 
TNF and do not completely revert the GRdim/dim sensitivity for TNF 
suggests that either the elimination of gut flora is incomplete, e.g., 
leaving certain resistant bacteria, viruses, and fungi intact, or that 
the contribution of ISGs is only partial. STAT1, however, is a cen-
tral player in TNF-induced lethal SIRS as well as gut permeability, 
as we show using STAT1–/– mice. Unfortunately GRdim/dimSTAT1–/– 
mice appeared not viable due to an unknown cause. Tofacitinib, a 
JAK/STAT1 inhibitor, like antibiotics, led to a marked yet incom-
plete reversal of the TNF sensitivity of GRdim/dim mice.
Our data suggest that endogenous GCs are (a) induced in a 
gut flora–dependent way as a result of the ISG signature, which 
includes the steroidogenic Cyp11a1 and Cyp11b1 genes, but (b) also 
repress ISGs via GR dimers. Since STAT1 is a central core node reg-
ulator of ISGs, it is conceivable that GR dimers block ISGs at the 
level of STAT1. Activated STAT1/STAT1 homodimers or STAT1/
STAT2 heterodimers translocate to the nucleus, where they par-
ticipate in the regulation of the expression of ISGs (26). GCs are 
known to modulate IFN signaling at different levels. First, GCs 
repress type I IFN production, leading to reduced expression of 
ISGs (30, 31). Second, GCs inhibit STAT1 activation at therapeutic, 
but also physiological, levels by repressing its mRNA and protein 
expression (32). Third, STAT1 phosphorylation and occupancy of 
ISRE sequences in the DNA are actively inhibited by GC treatment 
(33–35). Inhibition of the STAT1 system, including expression, 
phosphorylation, and occupancy of ISREs, might be an import-
ant part of the antiinflammatory capacities of GCs (34). However, 
we found no such evidence in GRdim/dim mice. Fourth, increased 
Stat1 expression could result from binding of GR dimers to GRE 
Figure 6. Exogenous GC treatment represses ISG signature in a GR dimer–
dependent way. (A–E) Analysis of the DEX repression on TNF-induced ISGs 
based on RNA-seq data. GRWT/WT (black) and GRdim/dim (white) mice were pre-
treated with vehicle or 10 mg/kg DEX for 30 minutes, followed by challenge 
with 50 μg or 12.5 μg TNF, respectively (n = 3 per group). RNA was isolated 
and Stat1 (A) and Ifit1 (B) mRNA expression were analyzed via qPCR. (C) 736 
ISGs were induced by TNF in GRWT/WT and GRdim/dim mice. The impact (LFC) 
of DEX pretreatment is depicted as a percentage of reduction. (D) In total, 
across GRWT/WT and GRdim/dim mice, 2,029 genes were induced by TNF, and 93 
genes were only significantly inhibited by DEX in GRWT/WT mice. (E) Average 
normalized counts determined by RNA-seq for Ripk3, which is one of these 
93 genes. All bars represent mean ± SEM, and statistical analysis was with 
2-way ANOVA. (F and G) GRdim/dim mice have an increased necroptosis sig-
nature in IECs. GRWT/WT (black) and GRdim/dim mice (white) were injected with 
PBS or 12.5 μg TNF (n = 5 per group). After 2 hours, Ripk3 was detected on 
ileum samples by IHC (F; white arrows; representative images are shown). 
(G) GRdim/dim mice were pretreated with vehicle (black) or 250 μg Nec1s 
(white). Thirty minutes later, mice were challenged with 12.5 μg TNF, and 
survival was monitored (n = 5 per group). P values for survival curves were 
analyzed with a log-rank test. ****P < 0.0001; ***P < 0.001; **P ≤ 0.01; *P 
≤ 0.05. (H) General overview of the interaction between the microbiota and 
local CS production in controlling the ISG signature in IECs. PRR, pattern 
recognition receptor; TNFR, TNF receptor.
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12-hour dark/12-hour light cycle in a conventional and specific patho-
gen–free (SPF) animal facility and received food and water ad libitum. 
All mice were used at 8 to 12 weeks of age.
Reagents. Recombinant mouse TNF was produced in E. coli and 
purified to homogeneity in our laboratories. TNF had a specific activ-
ity of 1.2 × 108 IU/mg and no detectable endotoxin contamination. 
DEX (D-4902) and FD4 FITC-dextran (FD4-1G, Mw 3,000–5,000 
Da) were purchased from Sigma-Aldrich NV. Recombinant TNF, DEX, 
and FITC-dextran were diluted in pyrogen-free PBS. Tofacitinib (CP-
690550) citrate (S5001; Shelleckchem Inc.) was diluted in 2% Tween 
80 with 0.5% methylcellulose diluted in PBS. Nec1s, a necroptosis 
inhibitor, was diluted in DMSO and was used as recently described (48).
Injections and sampling. All injections were given intraperitoneal-
ly except in Nec1s experiments, for which intravenous injections were 
used. Injection volumes were always adapted to the body weight of the 
mice. In lethality experiments, lethal response was followed until no 
further deaths occurred. FITC-dextran and tofacitinib were adminis-
tered via oral gavage. Blood was taken via cardiac puncture after seda-
tion of the mice with a ketamine/xylazine solution (Sigma-Aldrich NV). 
To obtain mouse serum, samples were allowed to clot overnight at 4°C. 
The next day, the cloth was removed and samples were centrifuged 
at 20,000 g for 3 minutes. Serum samples were stored at –20°C. For 
sampling of different organs and IECs, the mice were killed by cervical 
dislocation at indicated time points. IEC samples for RNA isolations 
were prepared as follows: ileum was dissected, extensively flushed with 
PBS, and incubated with lysis buffer (732 6802; Bio-Rad) supplement-
ed with 2-mercaptoethanol on ice for 5 minutes. Samples were then 
snap-frozen in liquid nitrogen. IEC samples for Western blot analysis 
were also snap-frozen. For histology, a piece of ileum was fixed in 4% 
paraformaldehyde and embedded in paraffin by a standard protocol.
Intestinal permeability. An in vivo permeability assay was performed 
using FITC-dextran as described previously (4). Three hours after TNF 
challenge, 100 μl FITC-dextran (25 mg/ml in PBS) was administered 
by oral gavage. Five hours later, blood was collected in an EDTA-coated 
tube and centrifuged at 500 g for 10 minutes. Plasma was collected and 
fluorescence was measured as follows: λexc/λem = 488/520 nm.
Tissue sections, histology, and immunohistochemistry. Tissue sec-
tions of 4 μm were cut and stained with H&E using standard protocols. 
Pictures were taken with an Olympus Bx51 Light microscope (×40). 
Tissue damage was quantified by 4 neutral observers using the necro-
tizing enterocolitis scoring system published and validated by Halpern 
et al. (28). The mean values of all estimations were used. Cell death 
was identified by TUNEL (Fluorescein In Situ Cell Death Detection 
Kit; Roche) according to the manufacturer’s protocol.
Immunohistochemistry of RIPK3. For immunochemistry, tissue 
sections were dewaxed, incubated in Dako Antigen Retrieval Solution 
(Agilent) at a boiling temperature for 20 minutes in a Pick cell cooking 
unit, and cooled down for 2.5 hours. Blocking buffer (5% goat serum in 
PBT, i.e., PBS, 0.1% BSA, and 1% Triton X-100) was added to the slides 
for 30 minutes at room temperature. Primary antibody against RIPK3 
(ADI-905-242-100; Enzo Life Sciences) was diluted 1:200 in PBT and 
incubated overnight at 4°C. Slides were then incubated with second-
ary antibody (goat anti-rabbit–labeled E0432, Dako, Agilent; 1:500 
in blocking buffer) and streptavidin–Alexa Fluor 568 (S11223, 1:500 
in blocking buffer). Counterstaining was done with Hoechst reagent 
(Sigma-Aldrich NV, 1:1,000 in PBS). Fluorescence microscopy was 
performed using a Zeiss Axioscan Z.1.
GRdim/dim mice, which was confirmed by the lower impact of DEX 
on the repression on TNF-induced ISGs in GRdim/dim compared 
with GRWT/WT mice. Whether GR dimers limit the expression of 
ISGs through inhibition of STAT1 or at the level of each individual 
ISG via their IRF or ISRE element is so far unclear. We identified 
93 genes induced of which induction by TNF, was prevented by 
DEX pretreatment in a GRWT/WT-specific way. In this group, we 
found Ripk3, Zbp1, and Mlkl, which are important mediators of 
necroptosis, a form of cell death recently associated with SIRS (29, 
41). Zbp1, also known as DAI, is a molecule known to be induced 
by microbial/viral stimuli and is able to lead to necroptosis, in 
combination with Ripk3, in the absence of Ripk1 (42–44). Mlkl is 
the major target of the Ripk1/Ripk3 heterodimer or Zbp1/Ripk3 
heterodimer, and cleavage of Mlkl eventually leads to necroptotic 
cell death. Clearly, these molecules behave like ISGs and are more 
highly expressed in and less repressed by DEX in GRdim/dim mice. 
Therefore, a more outspoken induction of necroptosis by TNF 
as well as a lack of repression of cell death by DEX in the IECs of 
GRdim/dim mice might form an attractive explanation of the pheno-
types discussed in this paper.
In conclusion (Figure 6H), we reveal a hitherto unknown physi-
ological pathway in the epithelial cells of the gut involving microbio-
ta-stimulated ISG expression via STAT1. The family of ISGs contains 
Cyp11a1 and Cyp11b1, which code for essential enzymes involved in 
local CS production. CS subsequently stimulates GR dimer formation 
and inhibits Stat1 and other ISG gene expressions. Interestingly, genes 
coding for proteins involved in cell death also belong to the family of 
ISGs, namely Ripk3, Zbp1, and Mlkl. Expression of these genes, as well 
as cell death, is inhibited by CS pretreatment. TNF stimulates STAT1 
and ISGs, including these cell death–promoting genes. In the absence 
of GCs or GR dimers, the induction of ISGs by microbiota and TNF 
is no longer properly controlled, leading to excessive TNF-induced 
cell death, permeability, and lethality. Our work suggests that GCs 
protect against acute TNF-induced inflammation, predominantly 
in IECs, by a dimer-dependent repression of microbiota- and TNF- 
induced ISGs, including the master regulator STAT1.
Which microbes are involved in this pathway and whether 
this is relevant in mammals without coprophagy behavior,  or only 
in mice, are not known. Moreover, since the role of TNF in real 
human pathologies may be different than in a mouse model of 
TNF-induced acute inflammation, and given the fact that, based 
on alternative splicing and alternative start codon use (as elegant-
ly shown by Cidlowski and his team), several different GR proteins 
with different functions are expressed in different tissues during 
diseases, the impact of our findings in other mouse models and in 
human patients will need further investigation (45).
Methods
Mice. GRdim/dim mice were generated by H.M. Reichardt et al. and kept 
on an FVB/N background (11). Heterozygous GRdim/WT mice were inter-
crossed to generate GRWT/WT and GRdim/dim homozygous mutant mice. 
All offspring were genotyped by PCR on genomic DNA isolated from 
toe biopsies. GRfl/fl mice (46) were crossed with Villin-Cre transgenic 
mice (47) and the offspring intercrossed to generate GRVillinKO and GRfl/fl 
mice, all on a C57BL6/J background. C57BL6/J WT mice and STAT1–/– 
mice were purchased from JANVIER LABS and the Jackson Laborato-
ry, respectively. Mice were kept in individually ventilated cages under a 
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(Thermo Fisher Scientific), membranes were incubated overnight at 
4°C with primary antibodies against p-STAT1 (1:1,000, catalog 9167S; 
Cell Signaling), STAT1 (1:1,000, catalog D1K9Y; Cell Signaling), and 
actin (1:5,000, catalog 691002; Bio-Connect). Blots were washed 
with PBST 0.1% and then incubated for 1 hour at room temperature 
with anti-rabbit antibody (1:10,000, catalog 926-32211; LI-COR) and 
anti-mouse antibody (1:10,000, catalog 926-32220; LI-COR). Immu-
noreactive bands were detected using the Odyssey Infrared Imager 
(LI-COR) and quantified using Image Studio Lite Version 4.0.
Isolation of mouse IECs and ChIP. IECs were isolated as previous-
ly described (51). Briefly, whole small intestines were cut into pieces 
and incubated at 37°C in DMEM containing 5% FCS and 1 mM DTT 
for 30 minutes. The remaining tissue was incubated in PBS containing 
1.5 mM EDTA for an additional 10 minutes. Supernatant was filtered 
using a 70 μm cell strainer and centrifuged for 5 minutes at 400 g; 
the cell pellet was resuspended in Opti-MEM (Gibco, Thermo Fisher 
Scientific). The ChIP assay protocol was based on that of Schmidt et 
al. (52). Mouse IECs diluted in Opti-MEM were immediately fixed in 
1% formaldehyde for 10 minutes at room temperature while gently 
shaking. The reaction was stopped by adding 125 mM glycine for 10 
minutes with shaking. Cells were washed with PBS, and pellets were 
lysed in lysis buffer supplemented with protease inhibitors (0.1% SDS, 
1% Triton X-100, 0.15 M NaCl, 1 mM EDTA and 20 mM Tris pH 8). 
Lysates were sonicated using a Bioruptor instrument (Diagenode) for 
30 minutes using 30 seconds on/30 seconds off intervals. Supernatant 
was taken and used as input and for immunoprecipitation. nProtein 
sepharose beads (GE Healthcare) were washed in incubation buffer 
(0.15% SDS, 1% Triton X-100, 0.15 M NaCl, 1 mM EDTA, 20 mM 
HEPES) and incubated with 1 μg BSA for 2 hours. Samples were first 
incubated with 5 μg anti-GR H300 antibody (catalog sc-8992; Santa 
Cruz Biotechnology Inc.) or IgG control (catalog 10500C; Invitro-
gen, Thermo Fisher Scientific) and then added to the blocked beads 
overnight. All incubations were performed at 4°C while rotating. The 
next day, samples were extensively washed using spin columns with 
0.35 μm pore size filters (MoBiTec) and eluted with elution buffer 
(1% SDS and 0.1 M NaHCO3) for 20 minutes. Next, supernatant was 
incubated with 200 mM NaCl, 20 μg/ml RNase A (QIAGEN) and 1 
mg/ml proteinase K (VWR International) for 2 hours at 55°C and for 
5 hours at 65°C. DNA was purified with the QIAquick PCR Purifica-
tion Kit according to the manufacturer’s protocol (QIAGEN). qPCR 
was performed using the Roche LightCycler 480 System (Applied 
Biosystems). The following primers for the STAT1 promoter were 
used: IR-nGRE1 (forward 5′-CCTGCTGCTCTCAAGGTT-3′; reverse 
5′-TGGTTGTCACTGCCTCGTACTT-3′) and IR-nGRE2 (forward 
5′-TGAAGCAGGCATCTGAGGG-3′; reverse 5′-CGAAGGTGGAA-
GAGTGGGAG-3′). Normalization of the ChIP data was done based on 
a method described by Haring et al., as follows (53): for each sample, 
data with GR-specific H300 antibody or IgG control were normalized 
to an input sample. This input sample is indicative of the presence and 
amount of chromatin used in the ChIP reaction. This DNA sample 
yields a PCR product with all primer sets used.
Antibiotic-mediated depletion of commensal bacteria. Mice were 
kept in individual cages and treated with a dilution of a 100 mg/l cip-
rofloxacin (Sigma-Aldrich NV), 500 mg/l ampicillin (Sigma-Aldrich 
NV), 500 mg/l metronidazole (Sigma-Aldrich NV), and 250 mg/l 
vancomycin (Duchefa Biochemie) solution in their drinking water for 
3 weeks. After 2 weeks, the presence of microflora was determined by 
qPCR analysis. RNA was isolated with the RNeasy Mini Kit 
(QIAGEN) according to the manufacturer’s instructions. RNA con-
centration was measured with the Nanodrop 1000 (Thermo Fisher 
Scientific), and 300–1,000 ng RNA was used to prepare cDNA with 
Superscript II (Invitrogen, Thermo Fisher Scientific). qPCR was per-
formed using the Roche LightCycler 480 System (Applied Biosyste-
ms). The best performing housekeeping genes were determined by 
geNorm (49). Results are given as relative expression values normal-
ized to the geometric mean of the housekeeping genes. Primers used 
for qPCR are depicted in Table 1.
RNA-seq analysis of IEC samples. Total RNA was isolated with the 
RNeasy Mini Kit (QIAGEN) according to the manufacturer’s instruc-
tions. Biological triplicates were used for every condition. RNA concen-
tration was measured, and RNA quality was checked with the Agilent 
RNA 6000 Pico Kit (Agilent Technologies) and sequenced on a Illumi-
na Genome Analyzer IIx. Data were mapped to the mouse (mm10) ref-
erence genome transcriptome with tophat2 (50). Only uniquely mapped 
reads were retained. Gene-level read counts were obtained with the 
HTSeq python package. Differential gene expression was assessed with 
the DESeq2 package, and the FDR was set at the 1% level. Functional 
analysis of DE gene lists was performed via IPA. Part of the comparison 
between different TNF conditions was also done using IPA. Motif find-
ing for multiple motifs or de novo motif finding was performed using 
HOMER software. We used the promoter region (start offset: –500; end 
offset: default) to search for known motifs and de novo motifs of length 
8, 10, 12, 14, and 16. Searching for specific motifs in a set of sequences 
was done with the meme suite. Visualizations were made using R soft-
ware. All original microarray data were deposited in the NCBI’s Gene 
Expression Omnibus database (GEO GSE113691).
Proteomics sample preparation, LC-MS/MS analysis, and data analysis. 
See Supplemental Methods.
Western blot analysis. For the detection of STAT1 and p-STAT1, 
protein was isolated out of IECs (lysis buffer with 0.1% SDS, 150 mM 
NaCl, 50 mM Tris pH 8, 1% NP-40, 0.5% deoxycholate, 0.5 mM EDTA 
supplemented with protease and phosphatase inhibitor cocktails from 
Roche). Protein samples containing 50 μg protein were separated by 
electrophoresis in a 10% gradient SDS polyacrylamide gel and trans-
ferred to nitrocellulose membranes (pore size, 0.45 μm). After block-
ing the membranes with 1:2 dilution of Starting Block/PBST 0.1% 
Table 1. Primer sequences used for qPCR
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